Published October 1986 | Version v1
Journal article

153Sm-EDTMP, a potential therapeutic bone agent

  • 1. Dow Chemical Co., Freeport, TX (USA)
  • 2. Harry S. Truman Memorial Veterans Hospital, Columbia, MO (USA)
  • 3. Missouri Univ., Columbia (USA). Dept. of Radiology
  • 4. Missouri Univ., Columbia (USA). Dept. of Chemistry

Description

Ethylenediaminetetramethylenephosphonic acid (EDTMP) forms a stable complex with Sm-153. Biodistributions in rats and rabbits show the complex to be an excellent bone agent. The nuclear properties of Sm-153 make it an ideal candidate for therapy. This paper discusses pre-clinical development of Sm-153-EDTMP as a therapeutic bone agent. (author)

Additional details

Publishing Information

Journal Title
J. Labelled Compd. Radiopharm.
Journal Volume
23
Journal Issue
10-12
Series
J. Labelled Compd. Radiopharm.
Journal Page Range
1344-1346
ISSN
0362-4803
CODEN
JLCRD

Conference

Title
6. international symposium on radiopharmaceutical chemistry.
Dates
29 Jun - 3 Jul 1986.
Place
Boston, MA (USA).